About ACAMI

VISION OF ACAMI

The Victorian Government partnered with La Trobe University to establish the Australian Centre for AI in Medical Innovation (ACAMI).

ACAMI delivers new and additional capabilities to Victoria’s world leading medical innovation and life sciences ecosystem.

Working with research partners across the biotech and pharma sector, academia and healthcare, ACAMI develops bespoke AI solutions to advance biomedical research from bench to bedside.

With a focus that across antigen discovery, drug design, lead optimisation, preclinical trials, clinical trials and into clinical practice, ACAMI uses the power of AI to deliver impact and accelerate the delivery of new medicines into our communities.

Drawing on capability from across La Trobe University, ACAMI has expertise in artificial intelligence, computer vision, machine learning, physical AI, diagnostics and virtual reality. Combined with a well-established clinical trials network and recognised leadership in producing industry-ready graduates.

ACAMI is able to provide flexible solutions to collaboration partners at all stages of growth, including industry-partnered PhD programs, contract research and collaborative applications for grant funding.

Focus Areas

ACAMI’s activities are focused across three streams of work to deliver benefit to the medical research sector through a focus on AI.

LEADING THE MEDICAL RESEARCH SECTOR IN THE INTEGRATION OF AI WITH RNA TECHNOLOGIES

Victoria is recognised nationally and globally as a leader in cutting-edge health and medical research. Our medical research sector supports more than 30,000 jobs across institutes, universities and industry, and our research community is continually generating incredible scientific breakthroughs. The state is home to 18 world-class medical research institutes, employing over 6000 people.

ACAMI will grow Victoria’s existing strength in medical research by using AI to speed up discovery of new antigens and optimise lead design, improve the efficacy and efficiency of preclinical and clinical trials, and enhance the way clinicians interact with patients to deliver new medicines.

Combined with a world-class RNA ecosystem, these capabilities will ensure Victoria is at the forefront of the next technological leap for medical science.